Breakthrough SARS-CoV-2 infections and prediction of moderate-to-severe outcomes during rituximab therapy in patients with rheumatic and musculoskeletal diseases in the UK: a single-centre cohort study - The Lancet Rheumatology
Rheumatoid arthritis-related autoimmunity alone does not increase cardiovascular risk
Frontiers Cancer risks in rheumatoid arthritis patients who received immunosuppressive therapies: Will immunosuppressants work?
What Is Rheumatoid Arthritis? Symptoms, Causes, Diagnosis, Treatment, and Prevention
PDF) ML-13 Primary central nervous system malignant lymphoma in a patient with rheumatoid arthritis receiving tocilizumab
Cardiovascular risk assessment in patients with rheumatoid arthritis using carotid ultrasound B-mode imaging
Frontiers Cancer risks in rheumatoid arthritis patients who received immunosuppressive therapies: Will immunosuppressants work?
A Phase 2 Trial of Peresolimab for Adults with Rheumatoid Arthritis
Increased Risk of Lung Cancer in Rheumatoid Arthritis and Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Matched Cohort Study with Cancer Registry Linkage - ACR Meeting Abstracts
Multi-omics approaches for biomarker discovery in early ovarian cancer diagnosis - eBioMedicine
The risk of second primary malignancies in colorectal cancer patients using calcium channel blockers